• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IXC 0.00% 8.0¢

INVEX THERAPEUTICS LTD

Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical... Invex Therapeutics (ASX:IXC) is an Australian-based, late-stage biopharmaceutical development Company with issued patents and multiple orphan drug designations focused on the repurposing of an already approved drug, Exenatide, for efficacious treatment of neurological conditions derived from or involving raised intracranial pressure. Our primary focus is on the orphan disease Idiopathic Intracranial Hypertension (IIH), a large and growing market opportunity with no regulatory cleared treatmentsMore

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IXC 03/05/24 10 2.5K
03/05/24 Last post  BalkanBroker Comments Created with Sketch.  10  Views Created with Sketch.  2.5K 
IXC 19/04/24 0 244
19/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  244 
IXC 12/04/24 0 270
12/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  270 
IXC 09/04/24 0 178
09/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  178 
IXC 08/04/24 0 167
08/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  167 
IXC 03/04/24 0 223
03/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  223 
IXC 22/03/24 0 187
22/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  187 
IXC 20/03/24 0 361
20/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  361 

See All Discussions arrow Created with Sketch.

Timeline

Details of Auditor Appointment/Resignation
19 Apr 13:43
 
Quarterly Activities/Appendix 4C Cash Flow Report
12 Apr 14:49
 
Change of Director's Interest Notice
09 Apr 13:16
 
Notification of cessation of securities - IXC
08 Apr 10:17
 
Change of Director's Interest Notice
03 Apr 11:16
 
Amendment to Appendix 3A.4
22 Mar 13:09
 
View More arrow Created with Sketch.
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $6.012M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 28219 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.6¢ 2202 1
View Market Depth
Last trade - 16.12pm 03/05/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.